TMS for Exposure Therapy Resistant OCD

PHASE3RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

May 16, 2022

Primary Completion Date

April 1, 2026

Study Completion Date

September 1, 2027

Conditions
1 Hz Real rTMS to the Pre-SMA1 Hz Sham rTMS to the Pre-SMA
Interventions
COMBINATION_PRODUCT

repetitive transcranial magnetic stimulation (rTMS)

rTMS (real versus sham) is used as adjuvant to ERP

Trial Locations (8)

1081 HZ

RECRUITING

Amsterdam UMC, location VU Medical Center, Amsterdam

Unknown

RECRUITING

GGZ inGeest, Amsterdam

NOT_YET_RECRUITING

Neurocare, Eindhoven

NOT_YET_RECRUITING

Neurocare, Groningen

NOT_YET_RECRUITING

Maastricht UMC+, Maastricht

NOT_YET_RECRUITING

Mondriaan, Maastricht

NOT_YET_RECRUITING

ProPersona, Nijmegen

NOT_YET_RECRUITING

Radboudumc, Nijmegen

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

GGZ inGeest

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

ProPersona

OTHER

collaborator

Maastricht University Medical Center

OTHER

collaborator

Mondriaan

UNKNOWN

collaborator

Neurocare

OTHER

lead

Amsterdam UMC, location VUmc

OTHER

NCT05331937 - TMS for Exposure Therapy Resistant OCD | Biotech Hunter | Biotech Hunter